RLBFX
Price
$40.07
Change
+$0.19 (+0.48%)
Updated
Nov 28 closing price
Net Assets
269.83B
TSUMX
Price
$14.48
Change
+$0.08 (+0.56%)
Updated
Nov 28 closing price
Net Assets
98.37M
Interact to see
Advertisement

RLBFX vs TSUMX

Header iconRLBFX vs TSUMX Comparison
Open Charts RLBFX vs TSUMXBanner chart's image
American Funds American Balanced R5
Price$40.07
Change+$0.19 (+0.48%)
VolumeN/A
Net Assets269.83B
Thornburg Summit I
Price$14.48
Change+$0.08 (+0.56%)
VolumeN/A
Net Assets98.37M
RLBFX vs TSUMX Comparison Chart in %
View a ticker or compare two or three
VS
RLBFX vs. TSUMX commentary
Nov 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBFX is a StrongBuy and TSUMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 270B vs. TSUMX (98.4M). RLBFX (1.97) and TSUMX (1.94) have matching dividends . RLBFX was incepted earlier than TSUMX: RLBFX (24 years) vs TSUMX (7 years). TSUMX (1.17) is less costly to investors than RLBFX (0.29). TSUMX is a more actively managed with annual turnover of: 66.54 vs. RLBFX (44.00). RLBFX has a lower initial minimum investment than TSUMX: RLBFX (250) vs TSUMX (2500000). TSUMX annual gain was more profitable for investors over the last year : 13.57 vs. RLBFX (11.23). RLBFX return over 5 years is better than : 42.75 vs. TSUMX (31.13).
RLBFXTSUMXRLBFX / TSUMX
Total Expense Ratio0.290.7141%
Annual Report Gross Expense Ratio0.291.1725%
Fund Existence24 years7 years-
Gain YTD17.80014.426123%
Front LoadN/AN/A-
Min. Initial Investment25025000000%
Min. Initial Investment IRAN/AN/A-
Net Assets270B98.4M274,390%
Annual Yield % from dividends1.971.94101%
Returns for 1 year11.2313.5783%
Returns for 3 years45.7441.08111%
Returns for 5 years42.7531.13137%
Returns for 10 years78.47N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNTI2.230.12
+5.69%
Senti Biosciences Inc.
AUTL1.410.04
+2.92%
Autolus Therapeutics plc
QURE27.51-0.12
-0.43%
uniQure NV
HALO71.40-1.26
-1.73%
Halozyme Therapeutics
BRRWU9.90-0.60
-5.71%
Columbus Circle Capital Corp I